anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Disclaimer

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 41,127
Current window 27,961-27,990
Pages 1,371
Rows per page 30
Component: Disclaimerclear collectionreset all
18 30 60

Component

27,961-27,990 of 41,127

filter-aware
43
Includes footnotes regarding accounting standards and scope of contribution.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials1 hit
45
Includes detailed footnotes regarding valuation, share pools, and ownership calculations.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
51
The slide uses a waterfall chart to decompose revenue growth into specific channels like retail, wholesale, e-commerce, and others.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
52
Uses waterfall charts to decompose revenue growth drivers.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
56
Standard legal disclaimer slide for a SPAC transaction.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
57
Lanvin | Investor Presentation Deck | 58 slidesLanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
58
Lanvin | Investor Presentation Deck | 58 slidesLanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
02
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
14
The slide uses a horizontal layout with four distinct trial descriptions, each paired with an icon.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
02
Limbach Holdings | Investor Presentation Deck | 25 slidesLimbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
15
The slide uses callouts to explicitly link current performance metrics to future expectations.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
17
Includes a footnote regarding the reconciliation of Adjusted EBITDA.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
21
The table highlights a reduction in net debt and total debt over the six-month period.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
23
Includes detailed breakdown of non-GAAP adjustments such as depreciation, stock-based compensation, and restructuring costs.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
24
Includes detailed footnotes regarding non-GAAP financial measures and specific calculation methodologies.Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations 1 hit
22
The slide provides a financial breakdown of assets as of August 31, 2021, including a disclaimer about FMV.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
02
Lindsay Corporation | Results Presentation Deck | 17 slidesLindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations 1 hit
15
Includes 2001-2020 averages for both metrics.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Beat · Action1 hit
02
LVMH | Results Presentation Deck | 28 slidesLVMH | Results Presentation Deck | 28 slides · LVMH
Conference presentation Investor relations 1 hit
28
The slide presents two separate tables for 2022 and 2021, including quarterly, half-year (H1), and nine-month (9M) figures.LVMH | Results Presentation Deck | 28 slides · LVMH
Conference presentation Investor relations 1 hit
02
MainStreet Bancshares | Results Presentation Deck | 31 slidesMainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Attention1 hit
02
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
16
The chart uses a vertical dotted line at 0.2 to denote a clinical efficacy threshold.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
02
Matson | Results Presentation Deck | 10 slidesMatson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations 1 hit
01
Slide 1
NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slidesNeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
02
NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slidesNeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
03
NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slidesNeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
06
The slide uses a Gantt-style visualization to map drug development stages against specific clinical indications and future catalysts.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
29
NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slidesNeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
02
Nuvalent | Investor Presentation Deck | 31 slidesNuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit